Hidradenitis suppurativa (HS) as a paradoxical adverse event (PAE) using anti-IL1 has not been reported in the literature. We herein report a case of paradoxical hidradenitis suppurativa due to anti-IL1… Click to show full abstract
Hidradenitis suppurativa (HS) as a paradoxical adverse event (PAE) using anti-IL1 has not been reported in the literature. We herein report a case of paradoxical hidradenitis suppurativa due to anti-IL1 agents for mevalonate kinase deficiency disease successfully treated with the addition of ustekinumab.
               
Click one of the above tabs to view related content.